Category:
Anti-tumor Preparations
Standard:
N;
Trabectedin for Injection (ET743) is an anti-tumor chemotherapy drug.
Strength: 0.25mg; 1g
It is in R&D stage.
US-ANDA in preparation.
Trabectedin for Injection is a sterile, lyophilized antineoplastic agent derived from marine organisms. Manufactured via semi-synthetic organic synthesis with strict aseptic processing to ensure high purity and potency.